NCT02619864 2023-08-04mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma MultiformeCanadian Cancer Trials GroupPhase 1 Completed15 enrolled
NCT03071874 2022-10-18Vistusertib (AZD2014) For Recurrent Grade II-III MeningiomasMassachusetts General HospitalPhase 2 Unknown28 enrolled